Canada | Imports and Exports | World | Antibiotics | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 2941 "Antibiotics" from Canada totalled $ 8.7 million in 2023. Sales of commodity group 2941 from Canada went up by 74% compared to 2022: exports of commodity group 2941 "Antibiotics" went up by $ 3.71 million (cumulative exports of commodity group 2941 from Canada amounted $4.99 million in 2022)
Exports of commodity group 2941 "Antibiotics" amounted to 0.001% of total exports from Canada (cumulative merchandise exports from Canada totalled $ 566 billion in 2023). The share of commodity group 2941 in total exports from Canada decreased by 0 p.p. compared to 2022 (it was 0% in 2022 and cumulative exports from Canada were equal to $ 596 billion).
Exports of commodity group 2941 amounted to 0.2% of total sales of group "" from Canada in 2023 (the value of exports of commodity group from Canada amounted to $4.33 billion in 2023). The share of exports of commodity group 2941 in sales of commodity group from Canada increased by 0.092 p.p. compared to 2022 (it was 0.108% in 2022, and exports of commodity group from Canada were $4.59 billion).
Where does Canada export Antibiotics?
Top export destinations of "Antibiotics" from Canada in 2023:
- USA with a share of 46% (4.07 million US$)
- France with a share of 20% (1.77 million US$)
- Switzerland with a share of 8.96% (780 thousand US$)
- Italy with a share of 5.77% (502 thousand US$)
- Germany with a share of 3.43% (299 thousand US$)
- China with a share of 3.19% (278 thousand US$)
- Brazil with a share of 3.08% (268 thousand US$)
- Korea with a share of 1.47% (128 thousand US$)
- India - 85 thousand US$
- Portugal - 82 thousand US$
Exports structure of 2941 - Antibiotics - from Canada in 2023 represented by the following main commodity groups:
- 69% (6.04 million US$): 294190 - Antibiotics & their derivatives (excl. of 2941); salts thereof
- 18% (1.56 million US$): 294130 - Tetracyclines & their derivatives; salts thereof
- 10.2% (893 thousand US$): 294110 - Penicillins & their derivatives with a penicillanic acid structure; salts thereof
- 1.92% (167 thousand US$): 294150 - Erythromycin & its derivatives; salts thereof
- 0.202% (17.5 thousand US$): 294120 - Streptomycins & their derivatives; salts thereof
- 0.117% (10.1 thousand US$): 294140 - Chloramphenicol & its derivatives; salts thereof
The value of imports of commodity group 2941 "Antibiotics" to Canada totalled $ 157 million in 2023. Sales of commodity group 2941 to Canada went up by 6.58% compared to 2022: imports of commodity group 2941 "Antibiotics" went up by $ 9.7 million (the value of imports of commodity group 2941 to Canada was equal to $147 million in 2022)
Imports of commodity group 2941 "Antibiotics" accounted for 0.028% of total import flow to Canada (in 2023, total imports to Canada amounted to $ 558 billion). The share of commodity group 2941 in total imports to Canada increased by 0.002 p.p. compared to 2022 (it was 0.025% in 2022 and cumulative imports to Canada were equal to $ 569 billion).
Imports of commodity group 2941 reached 1.9% of total imports of group "" to Canada in 2023 (imports of commodity group to Canada totalled $8.25 billion in 2023). The share of purchases of commodity group 2941 in total imports of commodity group to Canada increased by 0.3 p.p. compared to 2022 (it was 1.6% in 2022, and imports of commodity group to Canada accounted for $9.2 billion).
Where does Canada import Antibiotics from?
Top trading partners (import of "Antibiotics") of Canada in 2023:
- Italy with a share of 31% (49 million US$)
- China with a share of 23% (36 million US$)
- Brazil with a share of 18.8% (29 million US$)
- India with a share of 8.57% (13.4 million US$)
- Spain with a share of 8.46% (13.2 million US$)
- USA with a share of 2.32% (3.65 million US$)
- Portugal with a share of 1.94% (3.04 million US$)
- New Zealand - 1.28 million US$
- China, Macao SAR - 1.22 million US$
- Bulgaria - 957 thousand US$
Imports structure of 2941 - Antibiotics - to Canada in 2023 represented by the following main commodity groups:
- 77% (121 million US$): 294190 - Antibiotics & their derivatives (excl. of 2941); salts thereof
- 16.3% (25 million US$): 294110 - Penicillins & their derivatives with a penicillanic acid structure; salts thereof
- 5.21% (8.18 million US$): 294130 - Tetracyclines & their derivatives; salts thereof
- 0.505% (793 thousand US$): 294120 - Streptomycins & their derivatives; salts thereof
- 0.2% (315 thousand US$): 294150 - Erythromycin & its derivatives; salts thereof
- 0.04% (63 thousand US$): 294140 - Chloramphenicol & its derivatives; salts thereof
